Penumbra PEN
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Penumbra (PEN) Core Market Data and Business Metrics
Latest Closing Price
$277.35Price-Earnings Ratio
770.42Total Outstanding Shares
38.52 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
One Penumbra Place, Alameda, CA, 94502
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 413,670 Shares | 2.96 | 3/14/2025 | 1,224,870 Shares |
| 672,193 Shares | 2.02 | 2/28/2025 | 1,355,515 Shares |
| 453,234 Shares | 3.7 | 2/14/2025 | 1,678,058 Shares |
| 442,201 Shares | 3.24 | 1/31/2025 | 1,434,305 Shares |
| 533,179 Shares | 3.51 | 1/15/2025 | 1,872,148 Shares |
| 334,909 Shares | 5.48 | 12/31/2024 | 1,836,735 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $77.62 Million |
| Net Cash Flow From Financing Activities, Continuing | $-87.01 Million |
| Net Cash Flow From Financing Activities | $-87.01 Million |
| Net Cash Flow From Operating Activities | $168.48 Million |
| Exchange Gains/Losses | $-2.18 Million |
| Net Cash Flow From Operating Activities, Continuing | $168.48 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Diluted Average Shares | $39.27 Million |
| Cost Of Revenue | $439.62 Million |
| Revenues | $1.19 Billion |
| Net Income/Loss | $14.01 Million |
| Other Operating Expenses | $171.73 Million |
| Preferred Stock Dividends And Other Adjustments | $0 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $11.32 Million |
| Other Comprehensive Income/Loss | $-2.69 Million |
| Comprehensive Income/Loss Attributable To Parent | $11.32 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities | $382.25 Million |
| Inventory | $406.74 Million |
| Wages | $74.20 Million |
| Other Current Assets | $544.39 Million |
| Intangible Assets | $6.51 Million |
| Assets | $1.53 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||